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Screening For congenital hypothyroidism 

In Maltese newborns using cord blood 

R. Parascandolo*, A.E. Felice**, M. Rizzo**, P. Vassallo Agius* 
(on belw/lolthe Neoll(/ta/ Thyroid Screening COlllmittee) 
ABSTRACT: Routine screening for congenital hypothyroidism (CHT) has been introduced because clinical 
features of CHT may not be evident before the baby is a few weeks old and treatment at this stage may already 
be too late. Since a newborn testing programme employing liquid cord blood for other conditions had already 
been developed in the University of Malta and the Department of Health, we explored the possibility of 
implementing newborn thyroid testing using liquid cord blood. A similar programme had been implemented 
successfully in Finland and Philadelphia. Between September 1989 and August 1995 around 32,000 newborns 
were tested. This is nearly complete ascertainment. Preliminary testing was by radioimmunoassay for TSH. 
The sera of those with TSH levels more that 13mU/I were further tested for free T4. If the free T4 level was 
below 12 pmoIlI, the babies were recalled for clinical evaluation and repeat testing. Other babies were recalled 
for technical reasons, giving a total recall rate of 3.88%. CHT was identified in seven newborns and treatment 
started within 3 weeks of delivery. One baby was reported normal on screening but was suspected to have CHT 
on clinical grounds at 3 weeks of age, confirmed biochemically. Tne incidence of CHT in Malta is therefore 1 in 
4500. 
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Introduction 
The clinical diagnosis of congenital hypothyroidism 
during the neonatal period is difficult <md often missed 
with grievous developmental sequelae. Consequently, a 
number of newborn screening programmes have been 
implemented worldwide in order to detect the condition 
prior to the onset of symptoms. The benefit of screening 
to detect hypothyroidism in the newborn, and the 
subsequent early treatment of identified infants is 
supported by evidence that optimum intellectual 
performance occurs when thyroid replacement therapy is 
begun as early as possible I. 
The level of thyroid stimulating hormone (TSH) in 
cord blood is considered a true indicator of thyroid 
function in the newborn; the TSH level rises sharply a 
few minutes after birth and returns to nonnal within one 
week 2. Therefore. for the detection of hypothyroidism 
TSH estimation should be carried out immediately after 
birth or at least two days later. Commonly, heel prick 
blood samples are collected on filter paper about I to 2 
weeks postnatally. Considerable cost and effort is 
necessary to organise collections in this way. However, 
in countries where it is necessary to screen for other 
inborn errors of' metabolism as well as hypothyroidism, a 
few days until the baby has established feeding must be 
allowed before the blood samples can be collected. 
In this communication, we report our cxperience with 
a screening programme for congenital hypothyroidism in 
newborn infants by measurement of TSH levels in 
samples of cord blood. Cord blood was chosen because 
a screening programme for the detection of abnormal 
haemoglobins and thalassaemia based on cord blood had 
already been established in the Maltese Islands. 
Materials and Methods 
Umbilical venous blood was collected from the 
placental side of the cord after every delivery and stored 
at 4° C until it reached the laboratory. If for any reason 
this was not done, a venous sample was taken from the 
baby at the time of routine discharge from hospital (2nd 
to 3rcl day) or within the first week of life. 
Cord blood samples were initially assayed for TSH . 
Between September 1989 and December 1993 a 
radioimmunoassay kit (Diagnostic Products Corporation, 
Los Angeles; KTSDI) calibrated against the WHO 1st 
IRP 68/38 was used. This was changed to an enzyme 
immunoassay kit (Boehringer Mannhein Germany; 1488 
635) using the ES 300 automated immunoassay analyser 
calibrated as above. 
In a pilot study, 640 random samples of cord blood 
were analysed and the TSH distribution plotted as shown 
in Figure I. Twenty percent of the samples had a TSH 
level of 13mU/L or above. This value was arbitrarily 
taken as a cut ofllevel above which free thyroxine (FT4) 
was also estimated on these samples. 
FT4 was analysed by a radioimmunoassay kit 
(Diagnostic Products Corporation, Los Angeles; 
TKF41) . 200 random cord blood sera were analysed and 
the FT4 distribution was plotted as shown in Figure 2. 
The mean FT4 level was 15.9 pmol/L with a SO of 4.2. 
It was empirically decided that in the screening 
programme an FT4 level equal to or less than 12 pmol/L 
( 1 SO or more below the mean) would be an indication 
for recalling the infant for a second TSH and FT4 
estimation. 
During the programme, infants were recalled by letter 
sent to the parents explaining the need for repeat testing 
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Fig. 1 - TSH distribution in 640 cord sera 
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Fig. 2 - FT4 distribution in 200 cord sera 
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and urging them to bring their infant to the children's 
outpatients without delay so that a second blood sample 
could be taken. 
The diagnosis of congenital hypothyroidism was made 
when the TSH level remained high (above 13 m U/I) and 
the FT4 level decreased or remained unacceptably low 
compared to the first sample (ie <= 12 P mol/I). 
In this study, in an attempt to identify 'missed cases', a 
circular was sent to all the medical practitioners on the 
Island to ask whether they were aware of cases of 
congenital hypothyroidism that were diagnosed during 
the study period but which were missed by the screening 
programme. This circular was sent on two separate 
occasions but no cases were reported. 
Results 
In the 6 year period from September 1989 to August 
1995, 31,533 infants delivered at St.Luke's Hospital 
(28,283), Gozo General Hospital (1,985), peripheral 
clinics and homes (1,265), were screened (Table I). Of 
these, 1226 (3.88%) had a TSH level >= 13mU/L and 
were recalled to submit a second sample but 377 (30.7%) 
failed to attend for re-testing. There were no patients 
that presented in our clinics with signs and symptoms of 
congenital hypothyroidism. 
Table 1 - Results of screening programme 
Number of infants screened (01.09.89 TO 31.08.95) 
St Luke's Hospital 28283 
Gozo General Hospital 1985 
Clinics / Home 1265 
TOTAL 31533 
RECALLS .......... . . . .. 1226 (3 .88%) 

FAILED RECALLS ......... 377 

( 30.7% of recalls; 1.19% of total screened) 
POSITIVE CASES ........... 6 

FALSE NEGATIVES ......... 1 

Of those that were re-tested, 6 (1 male and 5 females) 
were found to have congenital hypothyroidism (Table 2). 
One female infant (case 7, Table 2) had an initial TSH 
value of 5.6mU/I and was passed as normal by the 
screening programme. Subsequently, she developed 
constipation and prolonged jaundice while she was still 
on the special care baby unit, and TSH / FT4 assays at 3 
weeks of age were consistent with a diagnosis of 
congenital hypothyroidism. None of the cases of 
hypothyroidism had a goitre . 
From these figures the' incidence of congenital 
hypothyroidism in the Maltese popUlation was found to 
be 1 in 4500 which is slightly lower than the worldwide 
incidence of approximately I in 3800 to 4000:1 . 
Discussion 
Screening of newborns for congenital hypothyroidism 
is a well established practice and over the past 20 years it 
has proved its benefit and efficacy 4. Indeed, about 9 
million infants are screened every year throughout the 
developed world. Screening for congenital hypo­
thyroidism commenced in Malta in September 1989 and 
by the end of August 1995,31,533 newborn infants had 
been screened. This is believed to be an almost complete 
ascertainment giving a prevalence for the condition of I 
in 4500 which is lower than the rest of Europe where the 
prevalence is I in 3500. 
Most centres use filter paper blood spot" taken at five 
days of age to measure either TSH ( Europe and Asia) or 
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Table 2 - Data on cases with Congenital Hypothyroidism 
INITIAL RECAll 
CASE GENDER TSH FT4 TSH FT4 AGE" 
(mU/l) (pmol/ l) (mU/l) (pmol/l) (clays) 
CBI M >60 2.8 >120 < 1.6 18 

CB2 F >60 6.8 >120 <1.3 5 

CB3 F >60 9.2 NA <1.7 11 

CB4 F 5.9 4.2 > 60 <1.6 II 

CBS F 13.1 7.3 15.1 4.6 6 

CB6 F 40.2 7.0 > 40 <1.7 18 

CB7 F 5.6 ND > 40 <1.3 22 

* age at the start of treatment with thyroxine 
ND = not clone NA = not available 
T4 (North America and Australia). With either approach 
congenital hypothyroidism will be missed in some 
infants s. Some centres like Finland, Philadelphia and 
Hong Kong have chosen to use corcl blood for screening. 
With this method, a higher percentage of positive cases 
are missed due to a delay in TSH elevation in these 
cases 6. 
A number of false positive results is accounted for by 
the dramatic surge of TS H which peaks by 30 minutes 
after birth and reverts to normal within a week. By 
arbitrarily setting the corcl bloocl TSH level to a cut off 
point> 13m U/L, 3.88(10 of the population screened had to 
be followed up. This recall rate is high compared to that 
of Finland (0.08%) where cord blood is also used for 
screening 7. In our series only about 70% of the patients 
who were recalled to the children's outpatients 
department actually turned up for repeat testing. This is 
far from satisfactory, considering that patients need only 
travel very short distances to reach the hospital. Tt 
suggests that more emphasis should be made on parent 
education about screening, and perhaps also through the 
content of thc Ictter sent to parents. 
In our series one case of congenital hypothyroidism 
(CB 7) was missed on screening because of a normal 
cord blood TSH value but at 3 weeks of age she had 
signs and symptoms suggestive of congenital 
hypothyroidism which was confirmed biochemically . 
This case underlines the need for ongoing clinical 
vigilance for hypothyroidism even in infants whose 
thyroid function was normal on screening 4. It IS 
interesting to note that 6 out of the 7 positive cases were 
female. In one study from Finland it was shown that the 
incidence of thyroid dysgenesis was higher among 
female infants S 
One case (CB 5) picked up by the screening had 
borderline TSH values with low FT4 levels. This case 
was still treated as a positive case but has to be 
confirmed and distinguished from transient 
hypothyroidism in the future . It is important to start 
treatment with T4 as early as possible if 
neurodcvelopmental delay is to be avoided. Two of our 
cases were started on treatment in the first week, two in 
the second week, two in the third week and one at 22 
days of age. 
At follow-up all patients are doing well and 
developing normally. Thc first patient who was detectcd 
in the programme also had congenital hydrocephalus that 
required shunting on several occasions but his mental 
and physical development is within normal limits . The 
developmental outcome of these cases, both physical and 
mental, will be the subject of another study in the future. 
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